a) To be given within 24 h after birth. When this is missed, it can be administered at first contact with health facility. All stable preterm and LBW babies should be administered a birth dose and 3 more doses with pentavalent/hexavalent combination vaccines.
b) An extra dose of Hepatitis B vaccine is permitted as part of a combination vaccine when use of this combination vaccine is necessary.
c) IPV can be given as part of a combination vaccine.
d) 3rd dose of Rota vaccine is not necessary for RV1 (GSK).
e) Influenza vaccine should be started after 6 months, 2 doses 4 weeks apart, usually in the pre-monsoon period. At other times of the year, the most recent available strain should be used. Annual influenza vaccination should be continued, for all, till 5 y of age. For those at high risk of Influenza related complications, annual vaccination should be continued till 18 years and beyond.
f) Single dose is to be given for the live attenuated Hepatitis A vaccine. The inactivated vaccine needs two doses.
g) 2nd dose of Varicella vaccine should be given 3-6 mo after dose 1. In catch up schedule, in those >12 years of age, the 2nd dose is to be given after 4 weeks.
h) Tdap should not be administered as the second booster of DPT at 4-6 y. For delayed 2nd booster, Tdap can be given after 7 y of age. A dose of Tdap is necessary at 10-12 y. If a dose of Tdap was administered at more than or equal to 9 y of age, the adolescent Tdap is not necessary. If Tdap is unavailable/unaffordable, it can be substituted with Td.
i) From 9-14 years, HPV vaccines are recommended as a 2-dose schedule, 6 months apart.
j) 9vHPV-Gardasil-9 is approved for boys between 9-14 years of age and females between 9-26 years of age. HPV4-SII is recommended for females and males between 9-26 years of age. Gardasil 4 is licensed till 45 years of age only for females.
k) From 15 y onwards and in immunocompromised subjects at all ages, HPV vaccines are recommended as a 3-dose schedule, 0-2-6 months.
l) Menactra is approved in a 2-dose schedule between 9-23 mo. Minimum interval between two doses should be 3 mo. Menveo is recommended as a
single dose schedule after 2 y of age. For those with ongoing exposure to meningococci, boosters are recommended every 5 years.m) In endemic areas